In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Alexza forms financing vehicle to support CNS agents

Executive Summary

Alexza Pharmaceuticals (aerosolized drug delivery to the lungs), along with private equity company Symphony Capital Partners and other co-investors, have formed Symphony Allegro with $50mm to fund development of Alexza's two Phase IIa candidates: AZ002 (alprazolam) for acute panic attacks and AZ004 (loxapine) for acute agitation in schizophrenia.
Deal Industry
  • Biotechnology
  • Medical Devices
  • Pharmaceuticals
  • Pharmaceuticals
    • Specialty Pharmaceuticals
    • Drug Delivery
      • Pulmonary
Deal Status
  • Final
Deal Type
  • Financing
    • Special-Purpose Financing Vehicle

Related Companies